semaglutide and knee pain Reverses Arthritis? What the New Study Really Shows Anti-obesity drug has life-changing benefits

[DOI] [PubMed] [Google Scholar] 27.Mutz J

Mazdutide is a dual GLP-1/glucagon receptor agonist, offering: - Once-weekly dosing - Strong metabolic impact - Favorable safety profile (mostly GI-related) Why It Matters

To save energy for vital organs, the body prematurely pushes hair follicles out of the Anagen (growth) phase and into the Telogen (resting/shedding) phase

The 2-4 hour plasma half-life might initially suggest benefit from divided doses, but the relevant biological effects persist far beyond plasma clearance

Clinical trials have demonstrated that individuals using semaglutide for weight management can lose an average of 15% to 20% of their body weight over 68 weeks